Inadequate aged-care funding is suspected of deterring Bupa NZ buyers while Ryman said that’s the reason it’s reducing care beds at new villages.
Ryman said its decision to reduce care beds is a direct response to government underfunding of aged care.
The cancer diagnostics firm has pushed up its processing in its US and NZ markets while seeking clarity on its reimbursement status with US medicare group Novitas.
Inner Cosmos is one of a growing number of firms working on medical devices that use implanted electrodes to interact with the brain.